Expression and prognostic significance of survivin in de novo acute myeloid leukaemia
Open Access
- 1 October 2000
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 111 (1) , 196-203
- https://doi.org/10.1111/j.1365-2141.2000.02328.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human MelanomaJournal of Investigative Dermatology, 1999
- Acute Myeloid LeukemiaNew England Journal of Medicine, 1999
- The Signal Transducer and Activator of Transcription STAT5b Gene Is a New Partner of Retinoic Acid Receptor in Acute Promyelocytic-Like LeukaemiaHuman Molecular Genetics, 1999
- Tumor Content of the Antiapoptosis Molecule Survivin and Recurrence of Bladder CancerNew England Journal of Medicine, 1999
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Expression of Fas antigen in acute myeloid leukaemia is associated with therapeutic response to chemotherapyBritish Journal of Haematology, 1996
- Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid LeukemiaScience, 1993
- Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO)British Journal of Haematology, 1991
- The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locusNature, 1990
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958